+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2020-2024 - Product Image

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2020-2024

  • ID: 5005574
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • ICON Plc
  • IQVIA Holding Inc.
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • MORE
Global Pharmaceutical Contract Research And Manufacturing (CRAM) Market 2020-2024.

The publisher has been monitoring the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 and it is poised to grow by USD 69.09 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. The report on the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets. In addition, growing need to focus on core competencies is anticipated to boost the growth of the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 as well.

Market Segmentation

The publisher's global pharmaceutical contract research and manufacturing (cram) market 2020-2024 is segmented as below:

Service:
  • CMO
  • CRO
Geographic Segmentation:
  • North America
  • APAC
  • Europe
  • ROW
Key Trends for global pharmaceutical contract research and manufacturing (cram) market 2020-2024 growth

This study identifies growing need to focus on core competencies as the prime reasons driving the global pharmaceutical contract research and manufacturing (cram) market 2020-2024 growth during the next few years.

Prominent vendors in global pharmaceutical contract research and manufacturing (cram) Market 2020-2024.

The publisher provides a detailed analysis of around 25 vendors operating in the global pharmaceutical contract research and manufacturing (cram) market 2020-2024, including some of the vendors such as Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddy's Laboratories Ltd., ICON Plc, IQVIA Holding Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., PRA Health Sciences Inc. and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • ICON Plc
  • IQVIA Holding Inc.
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
  • Vendor Analysis
Vendors covered
  • Market positioning of vendors
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddy's Laboratories Ltd.
  • ICON Plc
  • IQVIA Holding Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • Thermo Fisher Scientific Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Market in focus
8. Parent market
9. Market characteristics
10. Product / Service portfolio of key vendors included in the market definition
11. Market segments
12. Global - Market size and forecast 2019 - 2024 ($ billion)
13. Global market: Year-over-year growth 2019 - 2024 (%)
14. Five forces analysis 2019 & 2024
15. Bargaining power of buyers
16. Bargaining power of suppliers
17. Threat of new entrants
18. Threat of substitutes
19. Threat of rivalry
20. Market condition - Five forces 2019
21. Customer landscape
22. Market share by geography 2019-2024 (%)
23. Geographic comparison
24. North America - Market size and forecast 2019-2024 ($ billion)
25. North America - Year-over-year growth 2019-2024 (%)
26. APAC - Market size and forecast 2019-2024 ($ billion)
27. APAC - Year-over-year growth 2019-2024 (%)
28. Europe - Market size and forecast 2019-2024 ($ billion)
29. Europe - Year-over-year growth 2019-2024 (%)
30. ROW - Market size and forecast 2019-2024 ($ billion)
31. ROW - Year-over-year growth 2019-2024 (%)
32. Key leading countries
33. Market opportunity by geography ($ billion)
34. Impact of drivers and challenges
35. Vendor landscape
36. Landscape disruption
37. Industry risks
38. Vendors covered
39. Market positioning of vendors
40. Boehringer Ingelheim International GmbH - Overview
41. Boehringer Ingelheim International GmbH - Business segments
42. Boehringer Ingelheim International GmbH - Key offerings
43. Boehringer Ingelheim International GmbH - Key customers
44. Boehringer Ingelheim International GmbH - Segment focus
45. Cadila Healthcare Ltd. - Overview
46. Cadila Healthcare Ltd. - Business segments
47. Cadila Healthcare Ltd. - Key offerings
48. Cadila Healthcare Ltd. - Key customers
49. Cadila Healthcare Ltd. - Segment focus
50. Catalent Inc. - Overview
51. Catalent Inc. - Business segments
52. Catalent Inc. - Key offerings
53. Catalent Inc. - Key customers
54. Catalent Inc. - Segment focus
55. Dr. Reddy's Laboratories Ltd. - Overview
56. Dr. Reddy's Laboratories Ltd. - Business segments
57. Dr. Reddy's Laboratories Ltd. - Key offerings
58. Dr. Reddy's Laboratories Ltd. - Key customers
59. Dr. Reddy's Laboratories Ltd. - Segment focus
60. ICON Plc - Overview
61. ICON Plc - Business segments
62. ICON Plc - Key offerings
63. ICON Plc - Key customers
64. ICON Plc - Segment focus
65. IQVIA Holding Inc. - Overview
66. IQVIA Holding Inc. - Business segments
67. IQVIA Holding Inc. - Key offerings
68. IQVIA Holding Inc. - Key customers
69. IQVIA Holding Inc. - Segment focus
70. Laboratory Corporation of America Holdings - Overview
71. Laboratory Corporation of America Holdings - Business segments
72. Laboratory Corporation of America Holdings - Key offerings
73. Laboratory Corporation of America Holdings - Key customers
74. Laboratory Corporation of America Holdings - Segment focus
75. Lonza Group Ltd. - Overview
76. Lonza Group Ltd. - Business segments
77. Lonza Group Ltd. - Key offerings
78. Lonza Group Ltd. - Key customers
79. Lonza Group Ltd. - Segment focus
80. PRA Health Sciences Inc. - Overview
81. PRA Health Sciences Inc. - Business segments
82. PRA Health Sciences Inc. - Key offerings
83. PRA Health Sciences Inc. - Key customers
84. PRA Health Sciences Inc. - Segment focus
85. Thermo Fisher Scientific Inc. - Overview
86. Thermo Fisher Scientific Inc. - Business segments
87. Thermo Fisher Scientific Inc. - Key offerings
88. Thermo Fisher Scientific Inc. - Key customers
89. Thermo Fisher Scientific Inc. - Segment focus
90. Currency conversion rates for US$
91. Research Methodology
92. Validation techniques employed for market sizing
93. Information sources
94. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • ICON Plc
  • IQVIA Holding Inc.
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • MORE
The publisher Announces the Publication of its Research Report-Global Pharmaceutical Contract Research And Manufacturing (CRAM) Market 2020-2024.

The publisher recognizes the following companies as the key players in the global pharmaceutical contract research and manufacturing (cram) market: Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Catalent Inc., Dr. Reddy's Laboratories Ltd., ICON Plc, IQVIA Holding Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., PRA Health Sciences Inc. and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the growing need to focus on core competencies."

According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Catalent Inc.
  • Dr. Reddy's Laboratories Ltd.
  • ICON Plc
  • IQVIA Holding Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • PRA Health Sciences Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll